CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma

American Journal of Surgical Pathology

Volumn 31, Issue 4, 2007, Pages 637-641

  Blokx, Willeke A M ^a   Lesterhuis, Joost J ^a   Andriessen, Monique P M ^b   Verdijk, Marian A J ^a   Punt, Kees J A ^a   Ligtenberg, Marjolijn J L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

CDKN2A; Differential diagnosis; Melanoma; Metastasis; Mutation analysis; Primary; Skin

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARM; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DIFFERENTIATION; EXON; FEMALE; GENE DELETION; GENE MUTATION; GERM LINE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MELANOMA; MORPHOLOGY; MUTATIONAL ANALYSIS; SKIN METASTASIS; THICKNESS; TUMOR SUPPRESSOR GENE;

ADULT; BASE SEQUENCE; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P16; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS, SECOND PRIMARY; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 34147106152     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318030718d     Document Type: Article

References (7)

1. Blokx WA, Ruiter DJ, Verdijk MA, et al. INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor. Am J Surg Pathol. 2005;29:125-130.
2. Crowson AN, Magro CM, Mihm MC. The Melanocytic Proliferations. New York: Wiley-Liss; 2001.
3. Harland M, Holland EA, Ghiorzo P, et al. Mutation screening of the CDKN2A promoter in melanoma families. Genes Chromosomes Cancer. 2000;28:45-57.
4. Hashemi J, Platz A, Ueno T, et al. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Cancer Res. 2000;60:6864-6867.
5. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
6. Piccinin S, Doglioni C, Maestro R, et al. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression. Int J Cancer. 1997;74:26-30.
7. Ruas M, Peters G. The p16ink4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta. 1998;1378:F115-F177.